11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

Pediatric Acute Respiratory Distress Syndrome (PARDS) and Severe Pneumonia

Pediatric Acute Respiratory Distress Syndrome (PARDS) represents a catastrophic manifestation of acute hypoxemic respiratory failure resulting from direct or indirect alveolar-capillary membrane injury. Characterized by severe non-cardiogenic pulmonary edema, surfactant inactivation, microvascular thrombosis, and severe ventilation-perfusion mismatch, PARDS demands advanced critical care transport management. Interfacility teams must master diagnostic stratification, lung-protective mechanical ventilation, aeromedical gas law implications, and rescue modalities.

---

Defining PARDS: The PALICC-2 Consensus Framework

In 2023, the Pediatric Acute Lung Injury Consensus Conference (PALICC-2) updated the diagnostic criteria for PARDS across four core domains:

1. Timing: Clinical onset within 7 days of a recognized clinical insult (e.g., pneumonia, sepsis, aspiration, major trauma, near-drowning, severe burns, pancreatitis).
2. Chest Imaging: New unilateral or bilateral opacities on chest radiograph or CT, consistent with acute pulmonary parenchymal disease and not due primarily to atelectasis or pleural effusion. Unlike the adult Berlin definition, bilateral disease is not required.
3. Origin of Edema: Acute respiratory failure not fully explained by left ventricular heart failure or fluid overload. If doubt exists, echocardiography or invasive hemodynamic monitoring must exclude primary hydrostatic pulmonary edema.
4. Oxygenation Impairment: On invasive ventilation, OI ≥ 4 or OSI ≥ 5. On non-invasive ventilation (full-face mask CPAP or BiPAP of at least 5 cmH2O), P/F ≤ 300 or S/F ≤ 250. PALICC-2 also recognizes 'possible PARDS' and 'at risk for PARDS' categories, for example children on nasal high-flow support. Children with perinatal lung disease are excluded.

---

Oxygenation Metrics: Oxygenation Index (OI) and Oxygen Saturation Index (OSI)

Mathematical Derivations and Physiological Rationale

While adult ARDS (Berlin definition) relies upon the $PaO_2/FiO_2$ (P/F) ratio, pediatric critical care consensus recognizes that the P/F ratio ignores Mean Airway Pressure ($P_{aw}$ or MAP). In pediatric respiratory physiology, oxygenation is intimately linked to the continuous distending pressure maintaining alveolar recruitment. A child achieving a $PaO_2$ of 70 mmHg on 100% FiO2 with a $P_{aw}$ of $8\text{ cmH}_2\text{O}$ has substantially milder lung injury than a child requiring a $P_{aw}$ of $22\text{ cmH}_2\text{O}$ to attain that identical $PaO_2$.

The Oxygenation Index (OI) quantifies this relationship:

$$OI = \frac{P_{aw} \times FiO_2 \times 100}{PaO_2}$$

• $P_{aw}$: Mean Airway Pressure in $\text{cmH}_2\text{O}$
• $FiO_2$: Fraction of inspired oxygen (expressed as a fraction between 0.21 and 1.0, multiplied by 100 to yield a percentage)
• $PaO_2$: Arterial partial pressure of oxygen in $\text{mmHg}$ obtained from an arterial blood gas

Non-Invasive Alternative: Oxygen Saturation Index (OSI)

When an indwelling arterial catheter is absent, the Oxygen Saturation Index (OSI) provides a validated non-invasive surrogate, provided pulse oximetry saturation ($SpO_2$) is ≤ 97% (above 97%, the oxyhemoglobin dissociation curve flattens, decoupling $SpO_2$ from changes in $PaO_2$):

$$OSI = \frac{P_{aw} \times FiO_2 \times 100}{SpO_2}$$

PALICC-2 Severity Stratification (Invasive Ventilation)

PALICC-2 stratifies severity at least 4 hours after the initial diagnosis into two groups:

• Mild/moderate PARDS: OI < 16 (or OSI < 12)
• Severe PARDS: OI ≥ 16 (or OSI ≥ 12)
• (The original 2015 PALICC used three tiers: mild 4 to under 8, moderate 8 to under 16, and severe 16 or higher. Older references still use them.)

---

Lung-Protective Mechanical Ventilation in Transport

The overarching objective of transport ventilation in PARDS is to prevent Ventilator-Induced Lung Injury (VILI), which comprises volutrauma (alveolar overdistension), barotrauma (excessive transpulmonary pressure), atelectotrauma (shear stress from cyclic end-expiratory alveolar collapse and reopening), and biotrauma (inflammatory cytokine liberation into the systemic circulation).

Core Ventilator Strategy & Targets

1. Physiologic Tidal Volume: PALICC-2 recommends tidal volumes in the physiologic range of 6 to 8 mL/kg of predicted (ideal) body weight, reduced to 4 to 6 mL/kg when needed to keep plateau and driving pressures within limits.
2. Plateau Pressure ($P_{plat}$) Limits: Maintain $P_{plat} \le 28\text{ cmH}_2\text{O}$ in patients with normal chest wall compliance. In patients with reduced chest wall compliance (e.g., severe abdominal compartment syndrome, extensive burns, severe scoliosis), limit $P_{plat} \le 32\text{ cmH}_2\text{O}$. Keep driving pressure ($\Delta P = P_{plat} - PEEP$) strictly < 15 cmH2O.
3. Moderate-to-High PEEP Titration: Utilize pediatric PEEP/FiO2 titration grids. Adequate PEEP prevents atelectotrauma by stenting open unstable alveoli throughout expiration. In moderate-to-severe PARDS, PEEP is typically titrated between 10 and 15+ cmH2O, balanced against cardiac index and venous return.
4. Permissive Hypercapnia: Avoid escalating minute ventilation to chase normocapnia. PALICC-2 accepts respiratory acidosis down to a pH of about 7.20 in order to stay within pressure and volume limits.
   • Absolute Contraindications to Permissive Hypercapnia: Traumatic brain injury with intracranial hypertension, severe pulmonary hypertension, and severe myocardial depression.

---

Refractory Hypoxemia Rescues: Neuromuscular Blockade, Proning, and Inhaled Nitric Oxide

When hypoxemic failure progresses despite lung-protective ventilation, transport teams deploy specialized rescue strategies:

Neuromuscular Blockade in Transit

Continuous infusion or intermittent boluses of neuromuscular blocking agents (e.g., Cisatracurium 0.1–0.2 mg/kg IV or Vecuronium/Rocuronium) eliminate patient-ventilator dyssynchrony, abolish active exhalation against the mechanical breath, decrease systemic oxygen consumption (VO2), and optimize chest wall compliance during flight.

Prone Positioning Mechanics & Aeromedical Logistics

PALICC-2 does not recommend prone positioning as routine therapy, but it may be considered as a rescue in severe PARDS. Placing the child in the prone position (for 12 to 16 hours/day) redistributes transpulmonary pressure gradients, recruits dorsal atelectatic alveoli, uncompresses dependent lung segments from the overlying heart and abdominal viscera, and dramatically improves $V/Q$ matching. During interfacility transport, prone positioning can be safely maintained provided the endotracheal tube is scrupulously secured, pressure points and eyes are padded, and inline suctioning is accessible.

Inhaled Nitric Oxide (iNO): Selective Pulmonary Vasodilation

• Indications: PALICC-2 does not recommend routine iNO in PARDS. It may be considered for documented pulmonary hypertension or severe right ventricular dysfunction, and as a rescue or bridge to ECMO in severe cases.
• Dosing: Administer 10 to 20 ppm delivered directly into the inspiratory limb of the transport ventilator circuit via specialized delivery consoles (e.g., INOmax).
• Mechanism: Inhaled nitric oxide is an uncharged, lipid-soluble gas that diffuses across alveolar membranes into adjacent vascular smooth muscle. It stimulates soluble guanylyl cyclase, generating cyclic guanosine monophosphate (cGMP) and producing potent vasodilation strictly in ventilated alveolar units.
• Selective Action: Because iNO is rapidly scavenged and inactivated by hemoglobin in the pulmonary capillary lumen (forming methemoglobin and nitrate), it does not reach the systemic circulation and causes zero systemic hypotension. By selectively dilating vessels adjacent to well-ventilated alveoli, it redirects blood flow away from non-ventilated, consolidated lung zones, slashing intrapulmonary shunt fraction and serving as a critical transport bridge to Extracorporeal Membrane Oxygenation (ECMO).
• ECMO Referral: PALICC-2 recommends considering ECMO in severe PARDS when lung-protective strategies fail and the cause is potentially reversible. It does not set a single OI cutoff, although an OI around 40 is a traditional trigger for referral. Refer early so the child can still be moved safely (Section 6.6).

---

Severe Pediatric Pneumonia and Pleural Space Complications

Severe pediatric pneumonia can act as the primary trigger for PARDS or present with severe unilateral consolidation and parapneumonic collections.

• Microbial Etiologies:
  • Bacterial: Streptococcus pneumoniae (most common overall); Staphylococcus aureus (especially community-acquired MRSA expressing the Panton-Valentine leukocidin [PVL] toxin, causing rapid necrotizing pneumonia, cavitary lung abscesses, pneumatoceles, and massive hemoptysis); Group A Streptococcus.
  • Viral: RSV, influenza A/B, adenovirus, metapneumovirus.
  • Atypical: Mycoplasma pneumoniae, Chlamydia pneumoniae.
• Parapneumonic Effusion & Empyema: Fluid progression from simple sterile exudate to fibrinopurulent loculation. Physical exam demonstrates dullness to percussion, asymmetric chest expansion, absent breath sounds, and tracheal deviation.

Transport Management of Chest Tubes & Boyle's Law

Large pleural effusions compromising ventilation must undergo drainage (pigtail catheter or chest tube thoracostomy) prior to transport departure.

Transport Safety: Chest Tube Management Under Boyle's Law

• Boyle's Law ($P_1 V_1 = P_2 V_2$): As transport aircraft ascend and atmospheric pressure drops, trapped gas pockets expand inversely.
• NEVER CLAMP A CHEST TUBE IN TRANSIT! Clamping a chest tube in a patient with a bronchopleural fistula or active air leak will trap expanding air within the pleural space, rapidly transforming an evacuated hemithorax into a fatal tension pneumothorax at cruising altitude.
• Drainage System Integrity: Maintain drainage canisters in an upright, dependent position below the patient's thorax at all times. Connect to a functional water seal or one-way Heimlich flutter valve to ensure continuous egress of expanding air and fluid.

---

Severity Stratification & Ventilatory Benchmarks in PARDS

---

Realistic Transport Scenario: Transport of Severe Necrotizing PARDS to an ECMO Center

A neonatal-pediatric critical care transport team is dispatched via pressurized fixed-wing aircraft to transport a 4-year-old male (weight 16 kg) with severe necrotizing MRSA pneumonia. The child was intubated 12 hours prior and is failing conventional ventilation at the community hospital. Ventilator settings: Pressure Control mode, PIP 32 cmH2O, PEEP 14 cmH2O, Mean Airway Pressure ($P_{aw}$) 20 cmH2O, FiO2 1.0, RR 28 bpm. Radial arterial blood gas demonstrates: pH 7.22, PaCO2 58 mmHg, PaO2 50 mmHg, and HCO3 23 mEq/L.

The transport physician calculates the Oxygenation Index (OI):

$$OI = \frac{20 \times 1.0 \times 100}{50} = \frac{2,000}{50} = 40.0$$

Recognizing severe PARDS at a level that traditionally triggers ECMO referral (OI about 40), the team immediately initiates multimodal transport stabilization:

1. Neuromuscular Blockade: Administers cisatracurium IV bolus followed by continuous infusion to eliminate ventilator dyssynchrony.
2. Lung-Protective Adjustments: Transitions to Volume Control with guaranteed low tidal volume of 70 mL (4.4 mL/kg PBW), sets PEEP at 15 cmH2O, limiting $P_{plat}$ to 27 cmH2O, and embracing permissive hypercapnia.
3. Inhaled Nitric Oxide (iNO): Initiates iNO at 20 ppm inline with the transport ventilator. Within 20 minutes, PaO2 improves from 50 to 78 mmHg, reducing the calculated OI to 25.6.
4. Prone Transport Preparation: The team carefully positions the child prone on the aircraft transport stretcher with head aligned, chest rolls placed, and the ETT taped securely. Throughout the 2-hour flight at a cabin altitude of 4,000 feet, the patient maintains SpO2 91%–93%, arriving stably at the regional pediatric ECMO center without cardiac arrest.

---

Clinical Pearls for PARDS and Severe Pediatric Pneumonia